Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Der Internist
|
August 3, 1999
[Effect of enzyme compounds in coagulation and metastasizing malignant tumors]
J Drevs, C Unger
Journal of Internal Medicine
|
November 23, 2006
The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis
J Drevs, V Schneider
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
Surrogate marker in clinical studies with anti-angiogenic drugs
U Zirrgiebel, J Drevs
International Journal of Clinical Pharmacology and Therapeutics
|
December 31, 2002
Serial measurements of pharmacokinetics, DCE-MRI, blood flow, PET and biomarkers in serum/plasma--what is a useful tool in clinical studies of anti-angiogenic drugs?
K Mross, S Fuxius, J Drevs
Journal of Clinical Pharmacy and Therapeutics
|
January 4, 2013
A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single-dose Auron Misheil therapy in healthy male subjects
J Scheele, K Diergarten, J Drevs, et al.
Onkologie
|
February 5, 2003
Antiangiogenesis: current clinical data and future perspectives
J Drevs, C Laus, M Medinger, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy
F Kratz, R Müller-Driver, I Hofmann, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
DCE-MRI in clinical trials: data acquisition techniques and analysis methods
R Strecker, K Scheffler, M Büchert, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
November 27, 2009
[Isolated lymph node metastasis in pericardial fat flap after bronchial stump coverage]
J Fröhlich, C Rischke, J Rentschler, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2001
Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates
F Kratz, J Drevs, G Bing, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Der Internist
|
August 3, 1999
[Effect of enzyme compounds in coagulation and metastasizing malignant tumors]
J Drevs, C Unger
Journal of Internal Medicine
|
November 23, 2006
The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis
J Drevs, V Schneider
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
Surrogate marker in clinical studies with anti-angiogenic drugs
U Zirrgiebel, J Drevs
International Journal of Clinical Pharmacology and Therapeutics
|
December 31, 2002
Serial measurements of pharmacokinetics, DCE-MRI, blood flow, PET and biomarkers in serum/plasma--what is a useful tool in clinical studies of anti-angiogenic drugs?
K Mross, S Fuxius, J Drevs
Journal of Clinical Pharmacy and Therapeutics
|
January 4, 2013
A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single-dose Auron Misheil therapy in healthy male subjects
J Scheele, K Diergarten, J Drevs, et al.
Onkologie
|
February 5, 2003
Antiangiogenesis: current clinical data and future perspectives
J Drevs, C Laus, M Medinger, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy
F Kratz, R Müller-Driver, I Hofmann, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
DCE-MRI in clinical trials: data acquisition techniques and analysis methods
R Strecker, K Scheffler, M Büchert, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
November 27, 2009
[Isolated lymph node metastasis in pericardial fat flap after bronchial stump coverage]
J Fröhlich, C Rischke, J Rentschler, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2001
Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates
F Kratz, J Drevs, G Bing, et al.
Page
of 2